These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30959020)

  • 21. Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine.
    Chan MH; Chiu PH; Lin CY; Chen HH
    Schizophr Res; 2012 Apr; 136(1-3):96-103. PubMed ID: 22325078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of dehydroepiandrosterone and its steroid precursor pregnenolone against the behavioural deficits in CO-exposed mice.
    Maurice T; Phan V; Sandillon F; Urani A
    Eur J Pharmacol; 2000 Feb; 390(1-2):145-55. PubMed ID: 10708718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens.
    Razoux F; Garcia R; Léna I
    Neuropsychopharmacology; 2007 Mar; 32(3):719-27. PubMed ID: 16525415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.
    Kos T; Popik P; Pietraszek M; Schäfer D; Danysz W; Dravolina O; Blokhina E; Galankin T; Bespalov AY
    Eur Neuropsychopharmacol; 2006 May; 16(4):297-310. PubMed ID: 16288851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats.
    Koros E; Rosenbrock H; Birk G; Weiss C; Sams-Dodd F
    Neuropsychopharmacology; 2007 Mar; 32(3):562-76. PubMed ID: 16794564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the mGluR allosteric modulation in the NMDA-hypofunction model of schizophrenia.
    Doreulee N; Alania M; Mitaishvili E; Chikovani M; Chkhartishvili B
    Georgian Med News; 2009 Dec; (177):59-65. PubMed ID: 20090156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-training administration of anesthetic ketamine differentially affects rats' spatial and non-spatial recognition memory.
    Pitsikas N; Boultadakis A
    Neuropharmacology; 2009 Jul; 57(1):1-7. PubMed ID: 19376140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice.
    Jeevakumar V; Driskill C; Paine A; Sobhanian M; Vakil H; Morris B; Ramos J; Kroener S
    Behav Brain Res; 2015 Apr; 282():165-75. PubMed ID: 25591475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.
    Zugno AI; Julião RF; Budni J; Volpato AM; Fraga DB; Pacheco FD; Deroza PF; Luca RD; de Oliveira MB; Heylmann AS; Quevedo J
    Metab Brain Dis; 2013 Sep; 28(3):501-8. PubMed ID: 23775300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nicotinic α7 receptor agonist GTS-21 but not the nicotinic α4β2 receptor agonist ABT-418 attenuate the disrupting effects of anesthetic ketamine on recognition memory in rats.
    Pitsikas N
    Behav Brain Res; 2020 Sep; 393():112778. PubMed ID: 32579977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents.
    Popik P; Hołuj M; Kos T; Nowak G; Librowski T; Sałat K
    Neurotox Res; 2017 Nov; 32(4):544-554. PubMed ID: 28577066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of dopamine receptor blockade in the rodent nucleus accumbens on local field potential oscillations and motor activity in response to ketamine.
    Matulewicz P; Kasicki S; Hunt MJ
    Brain Res; 2010 Dec; 1366():226-32. PubMed ID: 20888326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stress and Ketamine, Bimodal Influence on Cognitive Functions.
    Trofimiuk E; Wielgat P; Braszko JJ; Car H
    Behav Brain Res; 2019 Mar; 360():354-364. PubMed ID: 30562568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of BNN27, a novel C17-spiroepoxy steroid derivative, on experimental retinal detachment-induced photoreceptor cell death.
    Tsoka P; Matsumoto H; Maidana DE; Kataoka K; Naoumidi I; Gravanis A; Vavvas DG; Tsilimbaris MK
    Sci Rep; 2018 Jul; 8(1):10661. PubMed ID: 30006508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.
    Hou Y; Zhang H; Xie G; Cao X; Zhao Y; Liu Y; Mao Z; Yang J; Wu C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():107-16. PubMed ID: 23603358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toluene exposure during the brain growth spurt reduces behavioral responses to noncompetitive N-methyl-D-aspartate receptor antagonists in adult rats.
    Chien TH; Chan MH; Tang YC; Chen HH
    Psychopharmacology (Berl); 2005 Nov; 182(4):468-74. PubMed ID: 16136300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia.
    Haller J; Szirmai M; Varga B; Ledent C; Freund TF
    Behav Pharmacol; 2005 Sep; 16(5-6):415-22. PubMed ID: 16148446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates.
    Shiigi Y; Casey DE
    Psychopharmacology (Berl); 1999 Sep; 146(1):67-72. PubMed ID: 10485966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ketamine on prepubertal Wistar rats: Implications on behavioral parameters for Childhood-Onset Schizophrenia.
    Damazio Pacheco F; Canever L; Antunes Mastella G; Gomes Wessler P; Kunz Godoi A; Hubbe I; da Costa Afonso A; Celso D; Quevedo J; Ioppi Zugno A
    Int J Dev Neurosci; 2019 Dec; 79():49-53. PubMed ID: 31678549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
    Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
    Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.